Femasys (FEMY) Cash & Current Investments (2020 - 2026)
Femasys (FEMY) posted Cash & Current Investments of $5.4 million for Q1 2026, down 41.88% on a QoQ basis from $9.3 million in Q4 2025, and up 40.99% year-over-year from $3.8 million in Q1 2025.
Femasys (FEMY) Cash & Current Investments (2020 - 2026) Analysis & Trends
Femasys' Cash & Current Investments history runs 7 years deep, the most recent figure standing at $5.4 million for Q1 2026.
- Quarterly Cash & Current Investments rose 40.99% year-over-year to $5.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.4 million (up 40.99% YoY) and the FY2025 annual result came in at $9.3 million, up 168.45% from the prior year.
- Cash & Current Investments was $5.4 million for Q1 2026 at Femasys, down from $9.3 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $21.8 million in Q1 2022 and bottomed at $3.2 million in Q2 2025.
- A 5-year average of $11.2 million and a median of $10.2 million in 2023 frame the typical range for Cash & Current Investments.
- Annual changes were most pronounced in 2024 — Cash & Current Investments plunged 84.11% — and 2025, when it surged 168.45%.
- Femasys' Cash & Current Investments stood at $13.0 million in 2022, then surged by 67.54% to $21.7 million in 2023, then plunged by 84.11% to $3.5 million in 2024, then jumped by 168.45% to $9.3 million in 2025, then plunged by 41.88% to $5.4 million in 2026.
- Business Quant data shows FEMY's Cash & Current Investments at $5.4 million in Q1 2026, $9.3 million in Q4 2025, and $4.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.13 Bn | 120.91 Bn | 1.96 Bn | 5.22 Bn |
| 2 | Becton Dickinson | 44.77 Bn | 43.95 Bn | 2.15 Bn | 816.00 Mn |
| 3 | Alcon | 33.17 Bn | 31.51 Bn | 1.53 Bn | 1.66 Bn |
| 4 | Medline | 33.04 Bn | 30.81 Bn | 1.84 Bn | 2.24 Bn |
| 5 | Resmed | 29.35 Bn | 27.69 Bn | 890.98 Mn | 1.66 Bn |
| 6 | West Pharmaceutical Services | 23.65 Bn | 23.21 Bn | 329.20 Mn | 435.80 Mn |
| 7 | Solventum | 14.03 Bn | 13.47 Bn | 1.10 Bn | 561.00 Mn |
| 8 | Cooper Companies | 13.90 Bn | 13.76 Bn | 735.40 Mn | 138.80 Mn |
| 9 | Align Technology | 12.05 Bn | 10.99 Bn | 736.59 Mn | 1.06 Bn |
| 10 | Femasys | 16.86 Mn | 11.47 Mn | - | 5.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.39 Mn |
| Dec 31, 2025 | 9.27 Mn |
| Sep 30, 2025 | 4.57 Mn |
| Jun 30, 2025 | 3.22 Mn |
| Mar 31, 2025 | 3.82 Mn |
| Dec 31, 2024 | 3.45 Mn |
| Sep 30, 2024 | 7.61 Mn |
| Jun 30, 2024 | 13.53 Mn |
| Mar 31, 2024 | 17.84 Mn |
| Dec 31, 2023 | 21.72 Mn |
| Sep 30, 2023 | 8.69 Mn |
| Jun 30, 2023 | 10.71 Mn |
| Mar 31, 2023 | 10.16 Mn |
| Dec 31, 2022 | 12.96 Mn |
| Sep 30, 2022 | 16.01 Mn |
| Jun 30, 2022 | 19.12 Mn |
| Mar 31, 2022 | 21.77 Mn |
| Dec 31, 2021 | 24.78 Mn |
| Sep 30, 2021 | 27.28 Mn |
| Jun 30, 2021 | 29.86 Mn |